Investors
& partners

"

New clinical data in Q3 2025

Join the future of back pain rehabilitation

World’s cause of disability

millions of patients in 2050


billion US dollars in 2016


With the growing demand for effective, movement-based therapy, we strongly believe LumbaCure® could revolutionize back pain recovery across medical, corporate, and athletic sectors. Backed by clinical research and real-world validation, it offers a unique opportunity for investors, business partners, and distributors to be part of this transformation.

Beyond its current applications, LumbaCure® is built to scale—with a roadmap toward market expansion, the integration of data-driven decision-making tools for therapists, and the exploration of new therapeutic fields in musculoskeletal care.

Interested?
Contact us to explore investment and partnership opportunities.

They support LumbaCure®

Our LumbaCure® project is financially supported by SPW Wallonia DGO6 and other financial partners

Our teams collaborate with renown R&D, operations and engineering partners